[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sahar Mohammed Gad\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":4},"100536603","chronic-kidney-disease-patient-in-chronic-myloied-leukemia-100536603",false,"NCT06266975","Chronic Kidney Disease Patient in Chronic Myloied Leukemia","Inclusion Criteria:1\\_ Chronic myloid leukemia patiants who diagonised by biopsy , 2\\_ CBC.\n\n\\-\n\nExclusion : 1\\_pts known to have CKD before diagnosed of CML. 2- known Diabetic pts 3-imaging suggestive CKD etiology rather than CML effect eg.PKD,renal stones,chronic pyelonephritis","ALL","18 Years","75 Years",{"count":19,"type":20},40,"ESTIMATED","OBSERVATIONAL","To study the Prevalence ,Characteristics and outcome of CKD in patiants with chronic myeloid leukemia .",[24],"Chronic Myeloid Leukemia in Remission","NOT_YET_RECRUITING","2024-02-16",{"date":28,"type":29},"2024-02-20","ACTUAL",{"date":31,"type":20},"2024-02",{"date":33,"type":20},"2026-11",{"name":35,"class":36},"Sahar Mohammed Gad","OTHER",""]